US 8980275
Targeted heterologous antigen presentation on calicivirus virus-like particles
granted A61KA61K2039/5256A61K2039/5258
Quick answer
US patent 8980275 (Targeted heterologous antigen presentation on calicivirus virus-like particles) held by Takeda Vaccines, Inc. expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/5256, A61K2039/5258, A61K2039/55505, A61K2039/55572